Michael Gelband’s Olema Pharmaceuticals OLMA Stock Holding History

Michael Gelband’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$877K	Buy	+70,142	New	+$940K	0.01%	1108
2026 Q1	–	Sell	-150,670	Closed	-$3.77M	–	1946
2025 Q4	$3.77M	Buy	+150,670	New	+$2.68M	0.03%	576
2025 Q3	–	Sell	-58,980	Closed	-$251K	–	1880
2025 Q2	$251K	Buy	+58,980	New	+$263K	﹤0.01%	1276
2025 Q1	–	Sell	-91,298	Closed	-$532K	–	1846
2024 Q4	$532K	Buy	91,298 +21,457	+31%	+$214K	﹤0.01%	1137
2024 Q3	$834K	Buy	+69,841	New	+$893K	0.01%	1023
2022 Q1	–	Sell	-30,677	Closed	-$287K	–	2547
2021 Q4	$287K	Buy	+30,677	New	+$636K	﹤0.01%	1676
2021 Q1	–	Sell	-21,629	Closed	-$1.04M	–	2465
2020 Q4	$1.04M	Buy	+21,629	New	+$1.01M	0.01%	841

Other funds holding OLMA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Michael Gelband's OLMA Position: Q2 2026 in Review

Michael Gelband opened a new position in Olema Pharmaceuticals (OLMA) in Q2 2026: 70,142 shares worth $877K. The stake represents 0.01% of the portfolio and ranks #1108 among its holdings. This is a return to the name: Michael Gelband previously reported a position in OLMA as recently as Q4 2025.

Michael Gelband first reported a position in OLMA in Q4 2020 and has held it in 7 quarters since. The position peaked at $3.77M in Q4 2025. 182 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

Michael Gelband held 70,142 shares of Olema Pharmaceuticals worth $877K as of Q2 2026.
Olema Pharmaceuticals was a new Michael Gelband position in Q2 2026.
Olema Pharmaceuticals made up 0.01% of Michael Gelband's portfolio in Q2 2026, its #1108 holding.
Michael Gelband first reported a position in Olema Pharmaceuticals in Q4 2020 and has held it in 7 quarters since.
Michael Gelband's Olema Pharmaceuticals position peaked at $3.77M in Q4 2025.
182 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.